APX-007 (anti-IL-6Ra)
|
Ab191916-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
APX-007 (anti-IL-6Ra)
|
Ab191916-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
APX-007 (anti-IL-6Ra)
|
Ab191916-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
APX-007 (anti-IL-6Ra)
|
Ab191916-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Befovacimab (anti-TFPI)
|
Ab191914-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2156634-62-5 |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
Befovacimab (anti-TFPI)
|
Ab191914-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2156634-62-5 |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
Befovacimab (anti-TFPI)
|
Ab191914-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2156634-62-5 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Befovacimab (anti-TFPI)
|
Ab191914-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2156634-62-5 |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Azintuxizumab (anti-SLAMF7)
|
Ab190144-5mg
|
ExactAb™, 已验证, 无载体, 重组, 低内毒素, Azide Free, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
1826819-57-1 |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
Azintuxizumab (anti-SLAMF7)
|
Ab190144-1mg
|
ExactAb™, 已验证, 无载体, 重组, 低内毒素, Azide Free, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
1826819-57-1 |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
Azintuxizumab (anti-SLAMF7)
|
Ab190144-10mg
|
ExactAb™, 已验证, 无载体, 重组, 低内毒素, Azide Free, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
1826819-57-1 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Azintuxizumab (anti-SLAMF7)
|
Ab190144-100μg
|
ExactAb™, 已验证, 无载体, 重组, 低内毒素, Azide Free, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
1826819-57-1 |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
SAR-113244 (anti-CXCR5)
|
Ab190142-5mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重组, ≥95%(SDS-PAGE&SEC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
SAR-113244 (anti-CXCR5)
|
Ab190142-1mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重组, ≥95%(SDS-PAGE&SEC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
SAR-113244 (anti-CXCR5)
|
Ab190142-10mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重组, ≥95%(SDS-PAGE&SEC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
SAR-113244 (anti-CXCR5)
|
Ab190142-100μg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重组, ≥95%(SDS-PAGE&SEC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
AB3-7 (anti-CLDN6)
|
Ab190114-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
AB3-7 (anti-CLDN6)
|
Ab190114-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
AB3-7 (anti-CLDN6)
|
Ab190114-10mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
AB3-7 (anti-CLDN6)
|
Ab190114-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Iladatuzumab vedotin (anti-CD79b)
|
Ab183320-5mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1906205-77-3 |
5mg
|
¥ 18879.9
|
期货,请咨询 |
阿拉丁 |
Iladatuzumab vedotin (anti-CD79b)
|
Ab183320-1mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1906205-77-3 |
1mg
|
¥ 7549.9
|
期货,请咨询 |
阿拉丁 |
Iladatuzumab vedotin (anti-CD79b)
|
Ab183320-10mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1906205-77-3 |
10mg
|
¥ 30299.9
|
期货,请咨询 |
阿拉丁 |
Iladatuzumab vedotin (anti-CD79b)
|
Ab183320-100μg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1906205-77-3 |
100μg
|
¥ 1509.9
|
期货,请咨询 |
阿拉丁 |